Collaborative Response to COVID-19 Pandemic, and Development of Treatment Guidelines

참고문헌 (10)

1. "WHO coronavirus disease-19 dashboard"[URL]
2. Yonghyun Lee, "Prevalence and Duration of Acute Loss of Smell or Taste in COVID-19 Patients", Journal of Korean Medical Science, 35(18), pp.1~6 (2020), 대한의학회[DOI]
3. Kim Sun Bean, "Interim Guidelines on Antiviral Therapy for COVID-19", Infection and Chemotherapy, 52(2), pp.281~304 (2020), 대한감염학회[DOI]
4. Kim Sun Bean, "Revised Korean Society of Infectious Diseases", National Evidence-based Healthcarea Collaborating Agency Guidelines on the Treatment of Patients with COVID-19, 2021, pp.53(1), 166~219[DOI]
5. Hong Kyung Soo, "Early Hydroxychloroquine Administration for Rapid Severe Acute Respiratory Syndrome Coronavirus 2 Eradication", Infection and Chemotherapy, 52(3), pp.396~402 (2020), 대한감염학회[DOI]
6. 최준용, "Convalescent Plasma Therapy for Coronavirus Disease 2019", Infection and Chemotherapy, 52(3), pp.307~316 (2020), 대한감염학회[DOI]
7. WHO Solidarity Trial Consortium, "Repurposed antiviral drugs for Covid-19 - Interim WHO solidarity trial results", N Engl J Med, 384, pp.497~511 (2021)
8. Beigel JH, "Remdesivir for the treatment of Covid-19 - final report", N Engl J Med, 383, pp.1813~1826 (2020)
9. Simonovich VA, "A randomized trial of convalescent plasma in Covid-19 severe pneumonia", N Engl J Med, 384, pp.619~629 (2021)
10. Libster R, "Early hightiter plasma therapy to prevent severe Covid-19 in older adults", N Engl J Med, 384, pp.610~618 (2021)

관련 논문AI추천